Sort
39,280 grants matching “leukemia”
Biochemistry of Eukaryotic Messenger RNA Synthesis
$389,590Ronald C. Conaway · Stowers Institute For Medical Research · R01 · FY2012 · GM
Alpha-Particle Immunotherapy of Cancer
$389,561David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$389,557Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
Towards Understanding Prostate Cancer Heterogeneity
$389,543Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · CA
Novel Approaches for Antitumor and Antiviral Agents
$389,541Barry M Trost · Stanford University · R01 · FY2015 · GM
Degrading therapeutically important kinases using small molecules
$389,510Nathanael Schiander Gray · Stanford University · R01 · FY2023 · CA
Induction of Tolerance to FVIII in Hemophilia
$389,467David William Scott · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2016 · HL
Induction of Tolerance to FVIII in Hemophilia
$389,467David William Scott · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2015 · HL
Induction of Tolerance to FVIII in Hemophilia
$389,467David William Scott · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2018 · HL
Modulation of cancer specific transcriptional factors with small molecules
$389,411Katerina V Gurova · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Direct chemical control of the hematopoietic master transcription factor PU.1
$389,375Gregory Man Kai Poon · Georgia State University · R01 · FY2021 · HL
Molecular basis for microtubule-destabilization dependent MYB degradation
$389,348Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Targeting BFL-1 in Acute Myelogenous Leukemia
$389,348Anthony G Letai · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Biology and targeting of mutant STAG2-mediated R loop accumulation
$389,347Zuzana Tothova · Dana-Farber Cancer Inst · P01 · FY2025 · CA
HUMORAL REGULATION OF NORMAL AND MALIGNANT HEMATOPOIESIS
$389,337Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
Chromatin Modifications by Histone Ubiquitination and Methylations
$389,337Ali Shilatifard · Northwestern University At Chicago · R01 · FY2014 · GM
MicroRNAs' Role in Hematopoietic Lineage Differentiation
$389,306Chang-Zheng Chen · Stanford University · R01 · FY2006 · HL
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME
$389,250Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME
$389,250Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME
$389,250Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME
$389,250Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Project 1: Tumor Microenvironment Initiators of the Metastatic Cascade in High-Risk Prostate Cancer
$389,239Joshua Michael Lang · University Of Wisconsin-Madison · P50 · FY2024 · CA
Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia
$389,192Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2022 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2023 · CA